FIGS, Inc. Form 8-K Summary
Business Context and Reporting Period
FIGS, Inc. filed a Current Report on Form 8-K covering events dated February 26, 2024. The filing states that the company announced results on February 28, 2024, for the three months and fiscal year ended December 31, 2023. FIGS designs and sells healthcare apparel and related products, although the filing does not provide operating detail.
Financial Results and Key Metrics
The filing references a results press release furnished as Exhibit 99.1 and a shareholder presentation posted to the company’s investor-relations website. The provided filing text does not include clear values for revenue, net income, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Daniella Turenshine, Chief Financial Officer and principal accounting officer, notified the company on February 26, 2024, that she will resign effective April 12, 2024.
- Ms. Turenshine is leaving to become chief financial officer of another company. The filing states that her resignation is not related to any disagreement regarding financial reporting, operations, policies, or practices.
- Ms. Turenshine will remain in her role through April 12 and plans to serve as an advisor thereafter as needed for transition support.
- Kevin Fosty, the company’s Vice President, Controller, will become Interim Chief Financial Officer and principal accounting officer effective April 12 while FIGS conducts a permanent CFO search.
Outlook, Risks, and Unusual Items
The CFO transition and pending permanent CFO search are the principal disclosed developments. Mr. Fosty has led accounting, financial reporting, tax, and financial controls since joining FIGS in April 2021. The filing does not provide financial guidance, an earnings outlook, contingencies, or specific risk estimates.
Important Facts to Verify
- Review Exhibit 99.1 and the shareholder slide deck for the December 31, 2023 revenue, profitability, cash flow, margin, balance-sheet, and guidance details not included in the provided text.
- Confirm the April 12, 2024 effective date of Ms. Turenshine’s resignation and the scope and duration of Mr. Fosty’s interim appointment.
- Monitor the company’s search for a permanent CFO and any subsequent disclosures regarding financial reporting or internal controls.
- Note that Items 2.02 and 7.01, including the earnings release, are furnished rather than filed for purposes of Section 18 of the Exchange Act.